Table 2.

Patients’ baseline characteristics

CAD patients, n = 70
Age, y, mean ± SD70.3 ± 11.7
No. male (%)45 (64.3)
No. with hypertension (%)63 (90)
No. with hypercholesterolemia (%)39 (55.7)
No. with diabetes mellitus (%)24 (34.3)
No. smoking (%)26 (37.1)
No. with BMI >25 kg/m2 (%)14 (20)
No. with ACS (%)12 (17.1)
 No. with STEMI (%)2/12 (16.7)
 No. with NSTEMI (%)6/12 (50)
 No. with UAP (%)4/12 (33.3)
No. with elective procedure (%)58 (82.9)
No. with PCI/stenting (%)31 (44.3)
No. of vessels affected (%)
 117 (24.3)
 210 (14.3)
 343 (61.4)
Maximal degree of stenosis (%)
 25–49%10 (14.3)
 50–74%15 (21.4)
 ≥75%45 (64.3)
  • Hypertension and hypercholesterolemia were defined according to ESC guidelines (68). Patients suffered from the following comorbidities: peripheral artery disease (4.3%), moderate or severe valvular disease (11.4%), atrial fibrillation (10%), chronic renal failure (2.9%), and positive history for transient ischemic attack or stroke (4.3%). ACS, acute coronary syndrome; BMI, body mass index; NSTEMI, non–ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction; UAP, unstable angina pectoris.